Evaluating posaconazole dosing regimens of the different formulations against Aspergillus spp. in adults: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation-Reference-Cited by-同舟云学术

Evaluating posaconazole dosing regimens of the different formulations against Aspergillus spp. in adults: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation

Published:2020-10 Issue:4 Volume:56 Page:106112
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Wei Xiao-Chen,Zhao Ming-Feng,Li Xin,Xiao Xia

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference20 articles.

1. Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia;Le Clech;Curr Res Transl Med,2020

2. Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis;Seyedmousavi;Expert Rev Anti Infect Ther,2013

3. Therapeutic drug monitoring of posaconazole: an update;Dekkers;Curr Fungal Infect Rep,2016

4. Posaconazole: a broad-spectrum triazole antifungal;Torres;Lancet Infect Dis,2005

5. Posaconazole (marketed as NOXAFIL) information,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on pharmacotherapy for fungal infections in allogeneic stem cell transplant recipients;Expert Opinion on Pharmacotherapy;2024-07-23

2. Evaluating omadacycline dosing regimens against drug-resistant pathogens including Staphylococcus aureus , Streptococcus pneumoniae and Haemophilus influenzae in adults: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation;Journal of Chemotherapy;2024-04-09

3. Progress of triazole antifungal agent posaconazole in individualized therapy;Journal of Clinical Pharmacy and Therapeutics;2022-12

4. A Review of Population Pharmacokinetic Models of Posaconazole;Drug Design, Development and Therapy;2022-10

5. Subtherapeutic concentrations of posaconazole tablet: determining risk factors and effectiveness of a standardized dose adjustment in hematology inpatients;Leukemia & Lymphoma;2022-09-29